Switzerland's stock market punches well above its size. Despite being a small country by European standards, the SIX Swiss Exchange hosts some of the world's most profitable and durable businesses — Nestlé, Roche, Novartis, ABB, Zurich Insurance — and a less-followed layer of industrial champions below the headline index.
For investors who screen systematically, Switzerland is worth a dedicated pass. Most screeners either ignore it or cover only the largest names. This guide explains how the Swiss equity market is structured, what to look for, and how to screen it effectively.
The SIX Exchange: market structure
SIX Swiss Exchange is Switzerland's primary stock exchange, headquartered in Zurich. It lists approximately 250 domestic Swiss companies plus a substantial number of international listings (primarily ETFs and structured products).
Key indices:
SMI (Swiss Market Index) — the 20 largest and most liquid Swiss companies. Heavily weighted toward healthcare (Roche, Novartis at ~35% combined) and consumer staples (Nestlé at ~15%). The SMI is a quality index almost by definition: the companies in it are global businesses with dominant market positions, high margins, and decades of consistent profitability.
SMIM (Swiss Mid Caps) — the 30 next-largest companies after the SMI. Includes industrial leaders, specialty financial services companies, and high-quality mid-cap businesses with strong international revenues.
SPI (Swiss Performance Index) — the broadest Swiss index, covering the full domestic market. The SPI includes smaller companies not in the SMI or SMIM and is where the most interesting screening opportunities tend to be.
What makes Swiss stocks different
CHF denomination — Swiss stocks trade in Swiss francs. For EUR or USD-based investors, currency exposure matters. The CHF has historically strengthened against both EUR and USD over multi-decade periods, acting as a structural tailwind for non-Swiss investors holding Swiss assets.
Premium valuations — Swiss companies, especially in healthcare and consumer staples, typically trade at premium valuations versus European peers. This is largely justified by superior profitability, fortress balance sheets, and dominant market positions. Screening on pure value metrics like P/E below 12 will exclude almost all good Swiss companies.
Dividend withholding tax — Switzerland applies a 35% withholding tax on dividends paid to non-residents. This is partially refundable via tax treaties (typically reducing to 15% for most treaty countries), but the process requires filing a refund claim. Income-focused investors should factor this into net yield calculations.
Low float for family-controlled names — Several Swiss companies have significant family or cross-ownership structures with low free floats. Volume and liquidity checks matter more than in markets with fully dispersed ownership.
Key sectors on SIX Exchange
Healthcare: Roche and Novartis
Two of the world's largest pharmaceutical companies anchor the Swiss market. Both are dividend payers with decades of consecutive increases, global revenue bases, and significant research pipelines in oncology, neuroscience, and immunology.
For screening pharma companies correctly:
- Use P/E adjusted for amortization of acquired intangibles (reported P/E overstates cheapness when large M&A creates accounting drag)
- Free cash flow yield (more reliable than reported EPS)
- Pipeline optionality (not in financial statements; requires qualitative research)
Industrials: the hidden champions
Below the SMI, SIX hosts a cluster of industrial businesses that are global leaders in narrow niches: precision instruments, specialty chemicals, automation equipment, escalators and elevators, and measurement technology. These are companies that receive almost no media coverage outside Switzerland but dominate their global markets.
These are the Swiss companies most accessible via systematic screening:
- ROIC above 12% (sustainable competitive advantage)
- Net margin above 8%
- Revenue growth 3-year CAGR > 3% (modest but consistent)
- Debt/Equity below 0.5
Financial services
Swiss financials go beyond UBS (which absorbed Credit Suisse in 2023). Cantonal banks, private banks, and specialty insurance companies are listed across the SIX. Many cantonal banks trade at persistent discounts to book value, making them interesting for P/B-focused screens. Swiss Re and Zurich Insurance are among the world's largest and most profitable insurers.
Consumer staples: Nestlé
Nestlé is the world's largest food company and one of the largest companies in Europe by market cap. It's a defensive holding that appears in quality screens due to its global brand portfolio, pricing power, and consistent cash generation — even if near-term earnings have faced pressure from portfolio restructuring.
Screening Swiss stocks: a practical approach
Step 1: Filter by exchange — Set exchange to SIX Swiss Exchange or country to Switzerland.
Step 2: Quality first, value second — Swiss stocks reward quality investing-oriented screening. Start with profitability:
- ROIC > 10%
- Net margin > 8%
- Gross margin > 30%
- Debt/Equity < 0.5
Step 3: Growth check — Swiss companies are not high-growth, but consistent mid-single-digit growth is standard for the best names:
- 3-year revenue CAGR > 3%
- EPS growth 5-year average > 3%
Step 4: Valuation — Accept premium valuations for quality. A P/E filter below 15 will exclude most of the interesting Swiss companies. More appropriate filters:
- P/E below 25 (after quality filters, this is still selective in the Swiss context)
- EV/EBITDA below 14
Step 5: Dividend check
- Dividend yield > 1.5%
- Payout ratio < 60% (room for dividend to grow)
- Consecutive years of dividend growth: 5+
The SMI as a quality benchmark
One practical use of Swiss stocks in a broader portfolio context: treat the SMI as a quality peer group. When screening European industrials, comparing candidates to Swiss equivalents provides a quality anchor. Companies that match SMI-level profitability (ROIC > 15%, net margin > 12%) at lower valuations — because they're listed in Germany, France, or Spain and receive less attention — may represent relative value.
Small and mid-cap opportunities in the SPI
The SPI's smaller constituents are where Swiss screening produces the most interesting results. These companies receive less analyst coverage and occasionally trade at meaningful discounts to intrinsic value. Finding them requires a screener with full SPI coverage — not just the top 20 or 50 names.
Key filters for Swiss small and mid-caps:
- Market cap CHF 50M–CHF 1B
- ROIC > 8%
- Revenue growth 3-year > 5%
- P/E below 20
- Average daily volume > CHF 100,000 (minimum tradeable liquidity)
Swiss market calendar notes
Swiss companies follow IFRS accounting, reporting in CHF. Annual results are typically released February–March, with half-year results in July–August. The Swiss fiscal year is calendar-year for most companies. Annual general meetings are held in spring with dividend payments shortly after.
Conclusion
Switzerland is a high-quality market that rewards patient investors willing to pay for durable businesses. The SMI contains world-class global companies available at European market hours with the structural currency advantage of CHF. Below the SMI, the SPI hosts a less-followed universe of industrial leaders and niche champions where systematic screening with a full-SPI tool can surface opportunities well before analyst coverage catches up.